Cardiovascular Magnetic Resonance Imaging's Prognostic Utility in the Evaluation of Hypertrophic Cardiomyopathy Patients' Long-Term Outcomes and Mortality: A Review
DOI:
https://doi.org/10.70749/ijbr.v3i6.1689Keywords:
CMR, HCM, Clinical AssessmentAbstract
Background: As an additional imaging modality, cardiac magnetic resonance imaging (CMR) is valuable in the evaluation of patients with suspected or diagnosed hypertrophic cardiomyopathy (HCM). Objective: Aim was to determine the effectiveness of cardiac magnetic resonance imaging to diagnose long term outcomes among patients of hypertrophic cardiomayopathy. Given that HCM in children is linked to a higher risk of mortality and worse long-term outcomes, the prognosis and quality of life for these children are greatly affected by the age at which symptoms first appear and the underlying cause of their condition. It is crucial to correctly assess the heart and determine the HCM phenotype in order to make a diagnosis, stratify the prognosis, and do follow-up. The anatomy and function of the heart can be studied by cardiac magnetic resonance (CMR) scans, which can characterize tissues and evaluate blood flow and perfusion. Using CMR, minor anomalies in the myocardial composition can be detected and the various phenotypic expression of HCM can be characterized. The capacity to assess the severity and breadth of cardiac fibrosis using parametric mapping or late-gadolinium enhanced sequences is exclusive to CMR and is especially helpful for clinical assessment and prognostic stratification of children with HCM. Furthermore, HCM in children may worsen with time. Since the pace, timing, and severity of disease progression differ from patient to patient, it is crucial to closely monitor diagnosed patients' hearts and do serial follow-up throughout their lifetimes. Focusing on its clinical function in diagnosis, prognosis, and serial follow-up, this review provides an updated overview of CMR's usage in childhood HCM.
Downloads
References
European Society of Cardiology. (2014). 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. European Heart Journal, 35(39), 2733–2779.
https://doi.org/10.1093/eurheartj/ehu284
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., Seidman, C. E., Towbin, J. A., Udelson, J. E., & Yancy, C. W. (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. Circulation, 124(24).
https://doi.org/10.1161/cir.0b013e318223e2bd
Maron, M. S., Maron, B. J., Harrigan, C., Buros, J., Gibson, C. M., Olivotto, I., Biller, L., Lesser, J. R., Udelson, J. E., Manning, W. J., & Appelbaum, E. (2009). Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. Journal of the American College of Cardiology, 54(3), 220-228.
https://doi.org/10.1016/j.jacc.2009.05.006
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014). Hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 64(1), 83-99.
https://doi.org/10.1016/j.jacc.2014.05.003
Masarone, D., Kaski, J. P., Pacileo, G., Elliott, P. M., Bossone, E., Day, S. M., & Limongelli, G. (2018). Epidemiology and clinical aspects of genetic Cardiomyopathies. Heart Failure Clinics, 14(2), 119-128.
https://doi.org/10.1016/j.hfc.2017.12.007
Sen-Chowdhry, S., Jacoby, D., Moon, J. C., & McKenna, W. J. (2016). Update on hypertrophic cardiomyopathy and a guide to the guidelines. Nature Reviews Cardiology, 13(11), 651-675.
https://doi.org/10.1038/nrcardio.2016.140
Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch-Herold, M., Kramer, C. M., Manning, W. J., Patel, M., Pohost, G. M., Stillman, A. E., White, R. D., & Woodard, P. K. (2010). Accf/Acr/AHA/Nasci/Scmr 2010 expert consensus document on cardiovascular magnetic resonance. Circulation, 121(22), 2462-2508.
https://doi.org/10.1161/cir.0b013e3181d44a8f
Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., Dubourg, O., Kuhl, U., Maisch, B., McKenna, W. J., Monserrat, L., Pankuweit, S., Rapezzi, C., Seferovic, P., Tavazzi, L., & Keren, A. (2007). Classification of the cardiomyopathies: A position statement from the European Society of Cardiology working group on Myocardial and Pericardial Diseases. European Heart Journal, 29(2), 270-276.
https://doi.org/10.1093/eurheartj/ehm342
Rapezzi, C., Aimo, A., Barison, A., Emdin, M., Porcari, A., Linhart, A., Keren, A., Merlo, M., & Sinagra, G. (2022). Restrictive cardiomyopathy: Definition and diagnosis. European Heart Journal, 43(45), 4679-4693.
https://doi.org/10.1093/eurheartj/ehac543
Ing, R., Ames, W., & Chambers, N. (2012). Paediatric cardiomyopathy and anaesthesia. British Journal of Anaesthesia, 108(1), 4-12.
https://doi.org/10.1093/bja/aer408
Sen-Chowdhry, S., Jacoby, D., Moon, J. C., & McKenna, W. J. (2016). Update on hypertrophic cardiomyopathy and a guide to the guidelines. Nature Reviews Cardiology, 13(11), 651-675.
https://doi.org/10.1038/nrcardio.2016.140
Simonetti, O. P., Kim, R. J., Fieno, D. S., Hillenbrand, H. B., Wu, E., Bundy, J. M., Finn, J. P., & Judd, R. M. (2001). An improved MR imaging technique for the visualization of myocardial infarction. Radiology, 218(1), 215-223.
https://doi.org/10.1148/radiology.218.1.r01ja50215
Mahrholdt, H., Wagner, A., Holly, T. A., Elliott, M. D., Bonow, R. O., Kim, R. J., & Judd, R. M. (2002). Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation, 106(18), 2322-2327.
https://doi.org/10.1161/01.cir.0000036368.63317.1c
Choudhury, L., Mahrholdt, H., Wagner, A., Choi, K. M., Elliott, M. D., Klocke, F. J., Bonow, R. O., Judd, R. M., & Kim, R. J. (2002). Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 40(12), 2156-2164.
https://doi.org/10.1016/s0735-1097(02)02602-5
Schulz-Menger, J., Bluemke, D. A., Bremerich, J., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Kim, R. J., Von Knobelsdorff-Brenkenhoff, F., Kramer, C. M., Pennell, D. J., Plein, S., & Nagel, E. (2013). Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing. Journal of Cardiovascular Magnetic Resonance, 15(1), 35.
https://doi.org/10.1186/1532-429x-15-35
Kwon, D. H., Smedira, N. G., Rodriguez, E. R., Tan, C., Setser, R., Thamilarasan, M., Lytle, B. W., Lever, H. M., & Desai, M. Y. (2009). Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 54(3), 242-249.
https://doi.org/10.1016/j.jacc.2009.04.026
Moon, J. C., Reed, E., Sheppard, M. N., Elkington, A. G., Ho, S., Burke, M., Petrou, M., & Pennell, D. J. (2004). The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 43(12), 2260-2264.
https://doi.org/10.1016/j.jacc.2004.03.035
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., & Elliott, P. M. (2013). A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). European Heart Journal, 35(30), 2010-2020.
https://doi.org/10.1093/eurheartj/eht439
Pieroni, M., Moon, J. C., Arbustini, E., Barriales-Villa, R., Camporeale, A., Vujkovac, A. C., Elliott, P. M., Hagege, A., Kuusisto, J., Linhart, A., Nordbeck, P., Olivotto, I., Pietilä-Effati, P., & Namdar, M. (2021). Cardiac involvement in Fabry disease. Journal of the American College of Cardiology, 77(7), 922-936.
https://doi.org/10.1016/j.jacc.2020.12.024
Muchtar, E., Blauwet, L. A., & Gertz, M. A. (2017). Restrictive cardiomyopathy. Circulation Research, 121(7), 819-837.
https://doi.org/10.1161/circresaha.117.310982
Mocumbi, A. O., Carrilho, C., Sarathchandra, P., Ferreira, M. B., Yacoub, M., & Burke, M. (2010). Echocardiography accurately assesses the pathological abnormalities of chronic endomyocardial fibrosis. The International Journal of Cardiovascular Imaging, 27(7), 955-964.
https://doi.org/10.1007/s10554-010-9753-6
Mocumbi, A. O., Ferreira, M. B., Sidi, D., & Yacoub, M. H. (2008). A population study of Endomyocardial fibrosis in a rural area of Mozambique. New England Journal of Medicine, 359(1), 43-49.
https://doi.org/10.1056/nejmoa0708629
Salemi, V. M., Rochitte, C. E., Shiozaki, A. A., Andrade, J. M., Parga, J. R., De Ávila, L. F., Benvenuti, L. A., Cestari, I. N., Picard, M. H., Kim, R. J., & Mady, C. (2011). Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of Endomyocardial fibrosis patients. Circulation: Cardiovascular Imaging, 4(3), 304-311.
https://doi.org/10.1161/circimaging.110.950675
White, J. A., & Fine, N. M. (2016). Recent advances in cardiovascular imaging relevant to the management of patients with suspected cardiac amyloidosis. Current Cardiology Reports, 18(8).
https://doi.org/10.1007/s11886-016-0752-7
Ruberg, F. L., Appelbaum, E., Davidoff, R., Ozonoff, A., Kissinger, K. V., Harrigan, C., Skinner, M., & Manning, W. J. (2009). Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. The American Journal of Cardiology, 103(4), 544-549.
https://doi.org/10.1016/j.amjcard.2008.09.105
Bang, C. N., Gerdts, E., Aurigemma, G. P., Boman, K., De Simone, G., Dahlöf, B., Køber, L., Wachtell, K., & Devereux, R. B. (2014). Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circulation: Cardiovascular Imaging, 7(3), 422-429.
https://doi.org/10.1161/circimaging.113.001275
Cuspidi, C., Facchetti, R., Bombelli, M., Sala, C., Tadic, M., Grassi, G., & Mancia, G. (2015). Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population. Journal of Hypertension, 33(10), 2133-2140.
https://doi.org/10.1097/hjh.0000000000000658
Klem, I., Shah, D. J., White, R. D., Pennell, D. J., Van Rossum, A. C., Regenfus, M., Sechtem, U., Schvartzman, P. R., Hunold, P., Croisille, P., Parker, M., Judd, R. M., & Kim, R. J. (2011). Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage. Circulation: Cardiovascular Imaging, 4(6), 610-619.
https://doi.org/10.1161/circimaging.111.964965
Kim, H. M., Hwang, I., Choi, H., Yoon, Y. E., & Cho, G. (2022). Prognostic implication of left ventricular hypertrophy regression after antihypertensive therapy in patients with hypertension. Frontiers in Cardiovascular Medicine, 9.
https://doi.org/10.3389/fcvm.2022.1082008
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., ... & Touyz, R. M. (2024). 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J, 45(38), 3912-4018.
Sayin, B. Y., & Oto, A. (2022). Left ventricular hypertrophy: Etiology-based therapeutic options. Cardiology and Therapy, 11(2), 203-230.
https://doi.org/10.1007/s40119-022-00260-y
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., ... & Kaski, J. P. (2023). 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). European heart journal, 44(37), 3503-3626.
https://doi.org/10.1093/eurheartj/ehad194
Stewart, M. H., Lavie, C. J., Shah, S., Englert, J., Gilliland, Y., Qamruddin, S., Dinshaw, H., Cash, M., Ventura, H., & Milani, R. (2018). Prognostic implications of left ventricular hypertrophy. Progress in Cardiovascular Diseases, 61(5-6), 446-455.
https://doi.org/10.1016/j.pcad.2018.11.002
Matusik, P. T., Heleniak, Z., Papuga-Szela, E., Plens, K., Lelakowski, J., & Undas, A. (2020). Chronic kidney disease and its impact on a Prothrombotic state in patients with atrial fibrillation. Journal of Clinical Medicine, 9(8), 2476.
https://doi.org/10.3390/jcm9082476
Khalid, K., Padda, J., Ismail, D., Abdullah, M., Gupta, D., Pradeep, R., Hameed, W., Cooper, A. C., & Jean-Charles, G. (2021). Correlation of coronary artery disease and left ventricular hypertrophy. Cureus.
https://doi.org/10.7759/cureus.17550
Maron, B. J., Spirito, P., Wesley, Y., & Arce, J. (1986). Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. New England Journal of Medicine, 315(10), 610-614.
https://doi.org/10.1056/nejm198609043151003
Norrish, G., Jager, J., Field, E., Quinn, E., Fell, H., Lord, E., Cicerchia, M. N., Ochoa, J. P., Cervi, E., Elliott, P. M., & Kaski, J. P. (2019). Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation, 140(3), 184-192.
https://doi.org/10.1161/circulationaha.118.038846
Lafreniere-Roula, M., Bolkier, Y., Zahavich, L., Mathew, J., George, K., Wilson, J., Stephenson, E. A., Benson, L. N., Manlhiot, C., & Mital, S. (2019). Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines? European Heart Journal, 40(45), 3672-3681.
https://doi.org/10.1093/eurheartj/ehz396
Beroukhim, R. S., Merlocco, A., Gerardin, J. F., Tham, E., Patel, J. K., Siddiqui, S., Goot, B., Farooqi, K., Soslow, J., Grotenhuis, H., Hor, K., Muthurangu, V., & Raimondi, F. (2023). Multicenter research priorities in pediatric CMR: Results of a collaborative Wiki survey. Scientific Reports, 13(1).
https://doi.org/10.1038/s41598-023-34720-9
Fahmy, A. S., Rowin, E. J., Chan, R. H., Manning, W. J., Maron, M. S., & Nezafat, R. (2021). Improved quantification of myocardium scar in late gadolinium enhancement images: Deep learning based image fusion approach. Journal of Magnetic Resonance Imaging, 54(1), 303-312.
https://doi.org/10.1002/jmri.27555
Van der Ven, J. P., Sadighy, Z., Valsangiacomo Buechel, E. R., Sarikouch, S., Robbers-Visser, D., Kellenberger, C. J., Kaiser, T., Beerbaum, P., Boersma, E., & Helbing, W. A. (2019). Multicentre reference values for cardiac magnetic resonance imaging derived ventricular size and function for children aged 0–18 years. European Heart Journal - Cardiovascular Imaging, 21(1), 102-113.
https://doi.org/10.1093/ehjci/jez164
Baggiano, A., Torto, A. D., Guglielmo, M., Muscogiuri, G., Fusini, L., Babbaro, M., Collevecchio, A., Mollace, R., Scafuri, S., Mushtaq, S., Conte, E., Annoni, A., Formenti, A., Mancini, M., Mostardini, G., Andreini, D., Guaricci, A., Pepi, M., Fontana, M., & Pontone, G. (2020). Role of CMR Mapping Techniques in Cardiac Hypertrophic Phenotype. Diagnostics, 10(10), 770–770.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
